Jagsonpal Pharmaceuticals Limited — Dividend/Bonus, 02-06-2026: Closure of Buy Back

Jagsonpal Pharma has wrapped up its share buyback, extinguishing 1.6 Cr equity shares through a tender offer. This move slims down total outstanding shares from 6.71 Cr to 6.55 Cr. A key outcome: promoter shareholding bumped up from 67.71% to 69.36%, tightening the company's capital structure.